je.st
news
Tag: results
Enanta Announces SVR12 Results Of 95% From AbbVie's GIFT-1 Study In Non-Cirrhotic, Japanese Patients With Genotype 1b Hepatitis C Virus1
2015-06-03 06:35:57| drugdiscoveryonline Home Page
Enanta Pharmaceuticals, Inc., a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, announced recently that new data from AbbVie’s phase 3 GIFT-I study, its investigational, all-oral, interferon (IFN)- and ribavirin (RBV)-free, two direct-acting antiviral treatment with ombitasvir/paritaprevir/ritonavir, was presented at the Annual Meeting of the Japan Society of Hepatology in Kumamoto, Japan
Tags: c
results
study
japanese
Servo Driven Ultrasonic Welding Technology Provides Sophisticated Results in Assembling Mini Medical Device
2015-06-02 12:31:12| Industrial Newsroom - All News for Today
A leading medical device manufacturing company uses Dukane's iQ Series Servo driven Ultrasonic Welding System to assemble Test Strips and gets sophisticated results. Assembling mini medical devices as test strips require precise, repeatable and consistent process control. The test strips are made of two thin layers...
Tags: results
technology
medical
mini
CP Rail, CN Rail stare down 'near impossible' comparisons to last year's gangbuster results
2015-06-02 08:31:29| Apparel - Topix.net
Canadian Pacific Railway CEO Hunter Harrison. CN and CP's revenue ton miles - a measurement of the total amount of freight shipped by a railway - have so far fallen 7.6 and 4.2 per cent, respectively, so far in the second quarter.
Tags: to
results
years
impossible
IntegraGen Presents Results of Two Studies during 2015 ASCO Meeting...
2015-06-01 20:27:19| Logistics - Topix.net
IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in oncology and autism, today announced the presentation of two studies during the 2015 American Society of Clinical Oncology Annual Meeting focusing on the association between miR-31-3p expression and clinical outcomes in metastatic colorectal cancer patients treated with panitumumab or cetuximab. The data presented further validates previous studies which have documented that miR-31-3p expression in the primary tumor of mCRC patients is predictive of the effect of anti-EGFR therapy.
Tags: results
studies
meeting
presents
Mirati Therapeutics presents preliminary results of MGCD265 tyrosine kinase inhibitor at ASCO 2015
2015-06-01 12:09:35| Logistics - Topix.net
Mirati Therapeutics, Inc. today presented data that demonstrated preliminary evidence of clinical activity from its investigational targeted tyrosine kinase inhibitor candidate, MGCD265, as part of the developmental therapeutics category at the 2015 American Society of Clinical Oncology Annual Meeting being held in Chicago from May 29-June 2, 2015. The Company also provided updates on its other targeted tyrosine kinase inhibitor, MGCD516, and spectrum-selective HDAC inhibitor, mocetinostat.
Tags: results
presents
preliminary
inhibitor
Sites : [525] [526] [527] [528] [529] [530] [531] [532] [533] [534] [535] [536] [537] [538] [539] [540] [541] [542] [543] [544] next »